8 Stocks Under $10 Skyrocketing Higher
Rosetta Genomic
Rosetta Genomic (ROSG) develops and commercializes diagnostic tests based on microRNAs. This stock is trading up 10.7% at $7.60 in recent trading.
Today's Range: $6.82-$7.89
52-Week Range: $1.40-$36.45 Volume: 1.3 million Three-Month Average Volume: 276,887 >>22 Biopharma Stocks With Breakout Potential From a technical perspective, ROSG has been on fire lately, skyrocketing from $1.40 to today's high of $7.89 a share on massive volume. That move has now pushed ROSG right below its 200-day moving average of $8.26. Traders should continue to look for long-biased trades if ROSG can manage to take outs its 200-day with high-volume. Look for a sustained move or close over $8.26 with volume that's near or above 276,887 shares. At last check, ROSG has hit $7.89 at the high of the day on volume that's well above its three-month average action. If we get that move soon, look for ROSG to challenge its March high of $9.60 and possibly take it out.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
